Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

about

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

Item

http://www.wikidata.org/entity/Q55103310

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@en

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@nl

type

Item

label

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@en

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@nl

prefLabel

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@en

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@nl

P1476

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.

@en

P2093

Chul-Koo Cho

http://www.w3.org/2001/XMLSchema#string

Eun Kyung Paik

http://www.w3.org/2001/XMLSchema#string

Hyung Jun Yoo

http://www.w3.org/2001/XMLSchema#string

Jin-Kyu Kang

http://www.w3.org/2001/XMLSchema#string

Mi-Sook Kim

http://www.w3.org/2001/XMLSchema#string

Won Il Jang

http://www.w3.org/2001/XMLSchema#string

Young-Seok Seo

http://www.w3.org/2001/XMLSchema#string

P2860

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery

Review and uses of stereotactic body radiation therapy for oligometastases

Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors.

Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.

Split-course radiotherapy: where do we stand?

Stereotactic body radiotherapy for oligometastases.

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report

Solitary metastases: illusion versus reality.

P304

548-554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYY062

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29722825

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5974783

http://www.w3.org/2001/XMLSchema#string